Xanthine oxidoreductase regulates macrophage IL1β secretion upon NLRP3 inflammasome activation
Open accessThe DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index.
Abstract
Activation of the NLRP3 inflammasome by microbial ligands or tissue damage requires intracellular generation of reactive oxygen species (ROS). We present evidence that macrophage secretion of IL1β upon stimulation with ATP, crystals or LPS is mediated by a rapid increase in the activity of xanthine oxidase (XO), the oxidized form of xanthine dehydrogenase, resulting in the formation of uric acid as well as ROS. We show that XO-derived ROS, but not uric acid, is the trigger for IL1β release and that XO blockade results in impaired IL1β and caspase1 secretion. XO is localized to both cytoplasmic and mitochondrial compartments and acts upstream to the PI3K–AKT signalling pathway that results in mitochondrial ROS generation. This pathway represents a mechanism for regulating NLRP3 inflammasome activation that may have therapeutic implications in inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“however, only a few studies investigated its role in macrophages and suggested involvement in inflammasome activation [144], regulation of cytokine expression [145] and defense against parasitic infection [146].”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [144]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602
Autophagy and Viruses: Adversaries or Allies?
Dong, X., & Levine, B. (2013) · Journal of Innate Immunity · doi:10.1159/000346388 · Cited by 4,430
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Hornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A., & Latz, E. (2008) · Nature Immunology · doi:10.1038/ni.1631 · Cited by 3,065
Nakahira, K., Haspel, J. A., Rathinam, V. A. K., Lee, S.-J., Dolinay, T., Lam, H. C., Englert, J. A., Rabinovitch, M., Cernadas, M., Kim, H. P., et al. (2011) · Nature Immunology · doi:10.1038/ni.1980 · Cited by 3,049
Activation and regulation of the inflammasomes
Latz, E., Xiao, T. S., & Stutz, A. (2013) · Nature Reviews Immunology · doi:10.1038/nri3452 · Cited by 2,884
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658
Uric Acid and Cardiovascular Risk
Feig, D. I., Kang, D.-H., & Johnson, R. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0800885 · Cited by 2,440
Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production
Saitoh, T., Fujita, N., Jang, M. H., Uematsu, S., Yang, B.-G., Satoh, T., Omori, H., Noda, T., Yamamoto, N., Komatsu, M., et al. (2008) · Nature · doi:10.1038/nature07383 · Cited by 2,014
Research works printed but not linked: 1
- Harris, J. et al. Autophagy controls IL-1beta secretion by targeting pro-IL-1beta for degradation. J. Biol. Chem. 286, 9587–9597 (2011) . · DOI · Paper page
Cited by
Items 101–200 of 270
Hyperuricemia remodels the serum proteome toward a higher inflammatory state
Cabău, G., Gaal, O. I., Badii, M. O., Nica, V., Mirea, A.-M., Hotea, I., Pamfil, C. A. M., Popp, R. A., Netea, M. G., Rednic, S., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107909 · Cited by 32
“Another explanation for the anti-inflammatory effect of allopurinol could lie in the inhibition of xanthine oxidoreductase, its therapeutic target, and the subsequent blocking of xanthine oxidasederived reactive species of oxygen.(94) Our data showing a long-term inflammatory potential of hyperuricemia in the absence…”
BackgroundAllopurinol protects against ischemic insults in a mouse model of cortical microinfarction
Zhang, Q., Lan, Y., He, X., Luo, C., Wang, Q.-M., Liang, F., Xu, G., & Pei, Z. (2015) · Brain Research · doi:10.1016/j.brainres.2015.07.010 · Cited by 31
NLRP3 inflammasome and lipid metabolism analysis based on UPLC-Q-TOF-MS in gouty nephropathy
Zhang, Y., Sui, X., Xu, Y., Gu, F., Zhang, A., & Chen, J. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4176 · Cited by 37
Hyperuricemia as a potential plausible risk factor for periodontitis
Chen, Z., Ye, L.-W., Zhao, L., Liang, Z., Yu, T., & Gao, J. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.109591 · Cited by 32
The versatile biochemistry of iron in macrophage effector functions
Behmoaras, J. V. (2021) · FEBS Journal · doi:10.1111/febs.15682 · Cited by 32
Kawachi, Y., Fujishima, Y., Nishizawa, H., Nakamura, T., Akari, S., Murase, T., Saito, T., Miyazaki, Y., Nagao, H., Fukuda, S., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.144762 · Cited by 30
Editorial: Obesity, metabolic phenotypes and COVID-19
Sanoudou, D., Hill, M. A., Belanger, M. J., Arao, K., & Mantzoros, C. S. (2022) · Metabolism · doi:10.1016/j.metabol.2021.155121 · Cited by 32
Hyperuricemia-induced complications: dysfunctional macrophages serve as a potential bridge
Gu, W., Zhao, J., & Xu, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1512093 · Cited by 36
Xanthine Oxidoreductase: A Novel Therapeutic Target for the Treatment of Chronic Wounds?
Fernandez, M. L., Stupar, D., Croll, T. I., Leavesley, D. I., & Upton, Z. (2017) · Advances in Wound Care · doi:10.1089/wound.2016.0724 · Cited by 33
“19 This correlation was further validated with the use of XOR-specific inhibitors and siRNA, both of which impair IL-1 b secretion in macrophages before and after stimulation with MSU, alum, and OCP crystals.”
InfluentialTakahashi, K., Mizukami, H., Osonoi, S., Ogasawara, S., Hara, Y., Kudoh, K., Takeuchi, Y., Sasaki, T., Daimon, M., & Yagihashi, S. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105392 · Cited by 29
Amor, M., Bianco, V., Buerger, M., Lechleitner, M., Vujić, N., Dobrijević, A., Akhmetshina, A., Pirchheim, A., Schwarz, B., Pessentheiner, A. R., et al. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-02064-3 · Cited by 38
“…(ITIH4, LRP8/APOER2, MBL2, DBN1, PARK7/DJ-1) [83–87], whereas proteins related to the progression of atherosclerosis (DIAPH1) [88], foam cell formation and macrophage ferroptosis (IDH1) [89], and endothelial dysfunction and reactive oxygen species (ROS) production (XDH) [90] were downregulated.”
BackgroundRegulation of Inflammasome by Autophagy
Liu, T. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-0606-2_7 · Cited by 32
Chen, M.-M., Guo, W., Chen, S.-M., Guo, X.-Z., Xu, L., Ma, X., Wang, Y., Xie, C., & Meng, L. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.78948 · Cited by 29
“XDH inhibitors was employed at 50, 100 or 200 μM in cellular system in reported studies [40, 41].”
MethodPigment Nephropathy: Novel Insights into Inflammasome-Mediated Pathogenesis
Giuliani, K. T. K., Kassianos, A. J., Healy, H. G., & Gois, P. H. F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081997 · Cited by 30
“Furthermore, ROS derived from the 147 activity of xanthine oxidase (XO), an enzyme which produces uric acid via purine catabolism, has 148 also been reported to elicit an inflammasome response [57].”
BackgroundThe Crucial Role of Xanthine Oxidase in CKD Progression Associated with Hypercholesterolemia
Kim, Y.-J., Oh, S.-H., Ahn, J., Yook, J.-M., Kim, C., Park, S.-H., Park, S.-H., & Kim, Y.-L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207444 · Cited by 28
“XO activity is increased in obesity, and XO inhibitors regulate the inflammatory process by inhibiting production of ROS and uric acid [32,33].”
BackgroundLin, Z., Xie, Y., Zhao, M.-C., Hou, P.-P., Tang, J., & Chen, G. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02173-7 · Cited by 31
Dapueto, R., Rodriguez‐Duarte, J., Galliussi, G., Kamaid, A., Bresque, M., Batthyány, C., López, G. V., & Escande, C. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101833 · Cited by 29
“ported to regulate NLRP3 inflammasome and to be potently inhibited by other nitroalkene [60].”
BackgroundToprover, M., Shah, B., Oh, C., Igel, T. F., Romero, A. G., Pike, V. C., Curovic, F., Bang, D., Lazaro, D. M., Krasnokutsky, S., et al. (2020) · Arthritis Research & Therapy · doi:10.1186/s13075-020-02260-6 · Cited by 26
Liu, Y., Zhang, M., Wang, T., & Zhang, J. (2025) · Journal of Asthma and Allergy · doi:10.2147/jaa.s529371 · Cited by 27
Elsayed, S., & Elsaid, K. A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1033520 · Cited by 25
“Recently, the activity of xanthine oxidase (XO) was implicated in the activation of NLRP3 inflammasome and IL-1β release in response to insoluble crystals (Ives et al., 2015).”
BackgroundMethodInfluentialBarut, G. T., Kreuzer, M., Bruggmann, R., Summerfield, A., & Talker, S. C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1099357 · Cited by 27
Yang, T., Pan, Q., Yue, R., Liu, G., & Zhou, Y. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112004 · Cited by 26
Zhang, F., Tong, M., Feng, R., Jin, C., Zhang, S., Meng, J., Zhang, M., & Liang, C. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112891 · Cited by 26
Karlsen, H., & Dong, T. (2015) · Analytical Methods · doi:10.1039/c5ay01678a · Cited by 23
Xanthine oxidoreductase activation is implicated in the onset of metabolic arthritis
Aibibula, Z., Ailixiding, M., Iwata, M., Piao, J., Hara, Y., Okawa, A., & Asou, Y. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.02.039 · Cited by 23
Kondo, M., Imanishi, M., Fukushima, K., Ikuto, R., Murai, Y., Horinouchi, Y., Izawa‐Ishizawa, Y., Goda, M., Zamami, Y., Takechi, K., et al. (2018) · American Journal of Hypertension · doi:10.1093/ajh/hpy157 · Cited by 27
Pathogenic role of innate immunity in a model of chronic NO inhibition associated with salt overload
Zambom, F. F. F., de Oliveira, K. C., Foresto‐Neto, O., Faustino, V. D., Ávila, V. F., Albino, A. H., Arias, S. C. A., Volpini, R. A., Malheiros, D. M. A. C., Câmara, N. O. S., et al. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00251.2019 · Cited by 23
de Oliveira, M. F., Medeiros, R. C. A., Mietto, B. S., Leal-Calvo, T., Mendonça, A. P. M., Rosa, T. L. S. A., da Silva, D. S., Girardi, K. D. C. D. V., Pereira, A. M. R., de Macedo, C. S., et al. (2021) · Immunological Reviews · doi:10.1111/imr.12962 · Cited by 28
Oxidative stress and programmed cell death in diabetic wounds: A comprehensive review
Hong, L., Li, M., & Fan, Y. (2025) · Science Progress · doi:10.1177/00368504251370676 · Cited by 25
“67 Additionally, uric acid, the end product of XO activity, is elevated in wound fl uids from chronic venous leg ulcers.”
Wu, L., Zhou, C., Wu, J., Chen, S., Tian, Z., & Du, Q. (2020) · Mediators of Inflammation · doi:10.1155/2020/6959741 · Cited by 24
“Moreover, a recent study demonstrated that xanthine oxidase- (XO-) derived mitochondrial ROS was the trigger for NLRP3 expression and finally its inflammasome activation [14].”
Backgroundde Oliveira, D. P., Garcia, E. D. F., de Oliveira, M. A., Cândido, L. C. M., Coelho, F. M., Costa, V. V., Batista, N. V., Queiroz‐Junior, C. M., Brito, L. F., Sousa, L. P., et al. (2021) · Planta Medica · doi:10.1055/a-1676-4371 · Cited by 21
“After being phagocytosed by macrophages, the MSU crystals trigger NLRP3 inflammasome components like caspase 1, responsible for cleaving pro-IL-1β into its active form IL-1β, which is involved in the production of the chemokines associated with neutrophil accumulation in the affected joint [38,39].”
BackgroundHe, J., Xiu, F., Chen, Y., Yang, Y., Liu, H., Xi, Y., Liu, L., Li, X., Wu, Y., Luo, H., et al. (2024) · Infection and Immunity · doi:10.1128/iai.00248-23 · Cited by 22
Baicalein protects against endothelial cell injury by inhibiting the TLR4/NF‑κB signaling pathway
Wan, C., Xu, M., Huang, S., Wu, Q., Yuan, Y., Deng, W., & Tang, Q. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.8266 · Cited by 25
Ting, K. K. Y. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1403915 · Cited by 21
Wu, Y., He, F., Li, Y., Wang, H., Shi, L., Wan, Q., Ou, J., Zhang, X., Huang, D., Xu, L., et al. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/7674240 · Cited by 20
Extracellular Vesicles from Candida haemulonii var. vulnera Modulate Macrophage Oxidative Burst
Oliveira, B. T. M., Dourado, T. M. H., dos Santos, P. W. D. S., Bitencourt, T. A., Tirapelli, C. R., Colombo, A. L., & Almeida, F. B. D. R. (2023) · Journal of Fungi · doi:10.3390/jof9050562 · Cited by 20
“Three fluorescent probes, 2′,7′-dichlorodihydrofluorescein diacetate (H2DCFDA), dihydroethidium (DHE), and 4-amino-5-methylamino-2′,7′-difluorofluorescein diacetate (DAF), were used to measure ROS, O2•−, and NO production, respectively.”
MethodInfluentialKim, M., Chang, J. Y., Lee, D. W., Kim, Y. R., Son, D. J., Yun, J., Jung, Y. S., Lee, D. H., Han, S., & Hong, J. T. (2023) · Molecular Immunology · doi:10.1016/j.molimm.2023.02.012 · Cited by 20
Fujishima, Y., Kita, S., Nishizawa, H., Maeda, N., & Shimomura, I. (2023) · Endocrine Journal · doi:10.1507/endocrj.ej23-0160 · Cited by 20
Zhou, Y. L., You, H., Zhang, A., Jiang, X., Pu, Z., Xu, G., & Zhao, M. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8812 · Cited by 20
FUN14 domain‐containing 1-mediated mitophagy suppresses interleukin-1β production in macrophages
Huang, J., Zhu, T., Rong, R., You, M., Ji, D., & Li, H. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106964 · Cited by 18
Nasi, S., Castelblanco, M., Chobaz, V., Ehirchiou, D., So, A. K.-L., Bernabei, I., Kusano, T., Nishino, T., Okamoto, K., & Busso, N. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.612440 · Cited by 17
“We have previously shown that xanthine oxidoreductase (XOR) is a cellular source of ROS that impacts on inflammasome activation (Ives et al., 2015) as well as immune regulation (Kusano et al., 2019).”
BackgroundSelf-citationWu, D., Li, J., Shen, R., Li, J., Yu, Y., Li, L., Deng, S., Liu, T., Zhang, T., Xu, Y. X., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.773150 · Cited by 21
“This cascade results in pore formation on the plasma membrane and mediates a process known as pyroptosis (He et al., 2015; Ives et al., 2015).”
BackgroundKim, M. Y., Bang, E., Hwangbo, H., Ji, S. Y., Kim, D. H., Lee, H., Park, C., Hong, S. H., Kim, G., & Choi, Y. H. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154705 · Cited by 17
Chen, D., Liang, Y., Liang, J., Shen, F., Cheng, Y., Qu, H., Wa, Y., Guo, C., Gu, R., Qian, J., et al. (2023) · Journal of Dairy Science · doi:10.3168/jds.2022-22383 · Cited by 17
Treat-to-target or treat-to-dissolve strategy to improve gout treatment
Richette, P., & Dalbeth, N. (2024) · Nature Reviews Rheumatology · doi:10.1038/s41584-024-01117-5 · Cited by 16
“A number of hypotheses have been put forward to explain this putative anti-inflammatory effect of ULT: simply lowering urate levels might alter the sensitivity of the NLRP3 inflammasome, and/or inhibiting xanthine oxidase might reduce NLRP3-generated IL-1β production in macrophages 6 .”
Wu, Z., Zhao, L., Guo, Y. M., Lin, C., Lu, P., He, Q., Zhou, Y., Wang, X., & Yu, T. (2025) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.14144 · Cited by 16
Protective effects of Cyclocarya paliurus on hyperuricemia and urate-induced inflammation
Zhu, L.-H., Xu, Y., Zhu, L., Zheng, X., Jiang, C., Liu, J., Zhang, J., & Yin, Z. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.105130 · Cited by 16
Tavares, L. D., Galvão, I., Costa, V. V., Batista, N. V., Rossi, L. C. R., de Brito, C. B., Reis, A. C., Queiroz‐Junior, C. M., Braga, A. D., Coelho, F. M., et al. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.ma1118-470rr · Cited by 16
Huang, K.-C., Chang, Y., Pranata, R., Cheng, Y.-H., Chen, Y., Kuo, P., Huang, Y.-H., Tzen, J. T. C., & Chen, R.-J. (2023) · Biology · doi:10.3390/biology12020329 · Cited by 14
“key roles in signal transduction in response to inflammation [6,21].”
BackgroundPing, K., Yang, R., Chen, H., Xie, S., Xiang, Y., Li, M., Lu, Y., & Dong, J. (2024) · Inflammation · doi:10.1007/s10753-024-02041-2 · Cited by 18
“Moreover, recent studies have shown that the PI3K/AKT signaling pathway is not only closely related to the inflammatory response, but is also an important upstream component involved in the activation of NLRP3 inflammasome activation [55, 56].”
Maresh, M. M., Abdelaziz, R. R., & Ibrahim, T. M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118307 · Cited by 16
Huang, D., Jia, N., Pei, C., Shen, Z., Zhao, S., Wang, Y., Wu, Y., Li, S., Li, S., & Wang, Z. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115623 · Cited by 13
Elsaid, K. A., Zhang, L. X., Zhao, T., Marks, A. J., Jenkins, D., Schmidt, T. A., & Jay, G. D. (2024) · Arthritis Research & Therapy · doi:10.1186/s13075-024-03455-x · Cited by 13
Li, Y., Lin, Z., Jin, H., Wei, F., Ma, S., & Zhang, B. (2025) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.101183 · Cited by 14
Sai, J., Xiong, L., Zheng, J., Liu, C.-G., Lu, Y., Wang, G., Wang, Y., Wang, T., Guan, X., Chen, F., et al. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/2758140 · Cited by 13
Zhang, T., Tsutsuki, H., Li, X., & Sawa, T. (2022) · The Journal of Biochemistry · doi:10.1093/jb/mvab158 · Cited by 13
Ishii, T., Taguri, M., Tamura, K., & Oyama, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-13970-4 · Cited by 15
A novel target for the promotion of dermal wound healing: Ryanodine receptors
Degovics, D., Hartmann, P., Németh, I. B., Árva-Nagy, N., Kaszonyi, E., Szél, E., Strifler, G., Bende, B., Krenács, L., Kemény, L. V., et al. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.01.021 · Cited by 14
NLRP3 as a sensor of metabolism gone awry
Neuwirt, E., Gorka, O., Saller, B. S., Groß, C. J., Madl, T., & Groß, O. (2021) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2021.03.009 · Cited by 13
Functional identification of soluble uric acid as an endogenous inhibitor of CD38
Wen, S., Arakawa, H., Yokoyama, S., Shirasaka, Y., Higashida, H., & Tamai, I. (2024) · eLife · doi:10.7554/elife.96962.3 · Cited by 13
Sanchez, C., Campeau, A., Liu‐Bryan, R., Mikuls, T. R., O’Dell, J. R., Gonzalez, D. J., & Terkeltaub, R. A. (2024) · Scientific Reports · doi:10.1038/s41598-024-74154-5 · Cited by 13
Wang, T.-T., Du, Y., Wang, W., Li, X., & Liu, H. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4326695 · Cited by 12
Inflammatory response of uric acid produced by Porphyromonas gingivalis gingipains
Jun, H., An, S., Kim, H., & Choi, B. (2020) · Molecular Oral Microbiology · doi:10.1111/omi.12309 · Cited by 12
Inflammation initiated by stressed organelles
Martinon, F. (2017) · Joint Bone Spine · doi:10.1016/j.jbspin.2017.06.005 · Cited by 13
“[15] Ives A, Nomura J, Martinon F, Roger T, LeRoy D, Miner JN, et al.”
BackgroundSelf-citationChoe, J., Choi, C.-H., Park, K., & Kim, S. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.08.139 · Cited by 12
Breed and adaptive response modulate bovine peripheral blood cells’ transcriptome
Pošćić, N., Montanari, T., D’Andrea, M., Licastro, D., Pilla, F., Ajmone‐Marsan, P., Minuti, A., & Sgorlon, S. (2017) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-017-0143-y · Cited by 12
“Recently, its role in recruiting macrophages through inflammasome activation has been investigated [72].”
BackgroundYoshida, S., Hagiwara, Y., Tsuchiya, M., Shinoda, M., Koide, M., Hatakeyama, H., Chaweewannakorn, C., Suzuki, K., Yano, T., Sogi, Y., et al. (2019) · Molecular Pain · doi:10.1177/1744806919858797 · Cited by 12
“reported that XO-derived reactive oxygen species, excluding uric acid, is the trigger for NLRP3 inflammasome activation and XO blockade impair it.(54) These mechanisms may explain the dissociation observed in the present study.”
BackgroundFebuxostat attenuates vascular calcification induced by vitamin D3 plus nicotine in rats
Amer, A. E., El‐Sheakh, A. R., Hamed, M. F., El‐Kashef, H. A., Nader, M. A., & Shehatou, G. S. G. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105580 · Cited by 10
Li, Y., Lin, Z., Wang, Y., Wu, H., & Zhang, B. (2023) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.14592 · Cited by 10
Kuo, H., Chang, L., Chen, T., Lee, K., Lee, K.-F., Chen, C., & Yu, H. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00195 · Cited by 10
“The regulation of NLRP3 inflammasome activation through the Akt-dependent pathway has also been reported (Ives et al., 2015).”
BackgroundPetrillo, A. D., Fais, A., Raho, N., Era, B., Cannea, F. B., Padiglia, A., Grecu, E., Murtas, D., Maxia, C., Sogos, V., et al. (2025) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaf231 · Cited by 10
Wu, Y. Y., Xu, R., Li, S., Wong, E. M., Southey, M. C., Hopper, J. L., Abramson, M. J., Li, S., & Guo, Y. (2022) · Environment International · doi:10.1016/j.envint.2022.107655 · Cited by 10
Shin, C. H., Kim, K., Jeeva, S., & Kang, S. (2021) · Cells · doi:10.3390/cells10061412 · Cited by 10
“Additionally, elevated levels of lipopolysaccharide and adenosine triphosphate activate the NLRP3 inflammasome [76].”
BackgroundKawasaki, R., Kukimoto, I., Nishio, E., Otani, S., Nishizawa, H., Maeda, Y., Iwata, A., & Fujii, T. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1589277 · Cited by 8
GRIM19 downregulation-induced pyroptosis of macrophages through NLRP3 pathway in adenomyosis
Liu, H., Zhao, Y., Yang, Y., Huang, W., & Lan, C. (2021) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2021.10.012 · Cited by 8
Influence of the inflammasome complex on psychiatric disorders: clinical and preclinical studies
Kwon, S., & Cheon, S. Y. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.2005027 · Cited by 9
Metabolic Regulation of Immune Response and Tissue Remodeling in Gouty Arthritis (Review)
Chen, Z., Wang, W., & Hua, Y. (2023) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukaryotgeneexpr.2022046409 · Cited by 9
Liu, Z., Jin, L., Ma, Z., Nizhamuding, X., Zeng, J., Zhang, T., Zhang, J., Zhou, W., & Zhang, C. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117531 · Cited by 9
Alcohol abuse is associated with enhanced pulmonary and systemic xanthine oxidoreductase activity
Fini, M. A., Gaydos, J., McNally, A., Karoor, V., & Burnham, E. L. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00570.2016 · Cited by 10
“AUDIT score 2 [1-4] 2 [1-4] 17 [13-32] 28 [17-37] <0.”
Malakoti, F., Alemi, F., Yeganeh, S. J., Hosseini, F., Shabestani, N., Samemaleki, S., Maleki, M., daneshvar, S. F., Montazer, M., & Yousefi, B. (2022) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14118 · Cited by 9
Wu, M., Cai, Y., Yang, Y., Hu, H.-M., Yao, Y., Yang, J. M., Deng, J.-J., & Wan, L. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e13215 · Cited by 11
Ehirchiou, D., Bernabei, I., Pandian, V. D., Nasi, S., Chobaz, V., Castelblanco, M., So, A. K. L., Martinon, F., Li, X., Acha‐Orbea, H., et al. (2024) · Arthritis Research & Therapy · doi:10.1186/s13075-024-03350-5 · Cited by 10
Self-citationLi, Q., Shen, J.-X., Xu, S., & Zhang, K. (2025) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-025-01070-x · Cited by 7
“Activation of the NLRP3 inflammasome cleaves procaspase-1 into activated caspase-1 (Ives et al .”
The interplay between NLRP3 inflammasome and metabolic signals in gouty arthritis
Cao, D., Pu, H.-Y., Yuan, X., Li, Z., Yu, X., & Shi, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1761121 · Cited by 12
“It improves cellular bioenergetics — restoring intracellular ATP levels and mitochondrial function — through activation of the salvage pathway, thereby inhibiting NLRP3-driven IL-1 b release and macrophage cell death (152).”
Chekaoui, A., Belguendouz, H., Lahmar, K., Mazari, F., Terahi, M., Hakem, D., Youinou, P., & Touil–Boukoffa, C. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2019.106119 · Cited by 7
Yan, T., Shan, H., Wang, Z., Zou, S., Chen, Z., Yu, W., Du, Q., & Dong, X. (2023) · Neurosurgical Review · doi:10.1007/s10143-023-02233-8 · Cited by 7
“…ischemia and hypoxia, xanthine dehydrogenase, a subtype of xanthine oxidoreductase, is converted into XO, which subsequently catalyzes to produce superoxide during the biosynthesis of uric acid products, thereby participating in the oxidative stress and inflammation during tissue damage [10, 21].”
BackgroundMonteiro, L. D. B., Archambault, A., Starchuck, L., Magaña, A. A., Oh, J. H., Dubland, J. A., Rakić, B., Patterson, A. E., Verchere, C. B., & Geltink, R. I. K. (2025) · Life Science Alliance · doi:10.26508/lsa.202403191 · Cited by 7
“Previous reports have shown that XOR inhibition – mediated reduction of IL-1 β levels is independent of changes in uric acid – mediated NLRP3 activation (Ives et al, 2015).”
InfluentialLang, K., Wang, X., Wei, T., Xu, N., Chen, S., Luo, Y., Li, H., Xu, Y., Yang, D., & Song, Y. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114023 · Cited by 6
Xue, F., Zhu, R., Li, J., Liu, Z., Niu, L., Chen, W., Wang, C., & Zheng, J. (2025) · Foods · doi:10.3390/foods14162765 · Cited by 8
“Model success was confirmed by measuring SUA levels in randomly selected mice from the NC and MC groups one hour prior to drug administration, as described previously [34].”
Jia, W., Wei, X., & Gong, X. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1705704 · Cited by 6
Proteoglycan 4 (PRG4)/Lubricin and the Extracellular Matrix in Gout
Elsaid, K. A., Jay, G. D., Liu‐Bryan, R., & Terkeltaub, R. A. (2023) · Gout Urate and Crystal Deposition Disease · doi:10.3390/gucdd1030012 · Cited by 9
“This is in line with a previous study, in which ROS generated from XOR were identified as a significant driver of NLRP3 inflammasome activation and IL-1 β production [91].”
The Role of Histone Deacetylases in NLRP3 Inflammasomesmediated Epilepsy
Kuang, X., Chen, S., & Ye, Q. (2023) · Current Molecular Medicine · doi:10.2174/1566524023666230731095431 · Cited by 7
McCreery, C. V., Alessi, D., Mollo, K., Fasano, A., & Zomorrodi, A. R. (2025) · BMC Medicine · doi:10.1186/s12916-025-03854-0 · Cited by 6
“Xanthine oxidase has been shown to polarize immune cells into a pro-inflammatory phenotype [54].”
Sedda, D., Mackowiak, C., Pailloux, J., Culerier, E., Dudas, A., Rontani, P., Erard, N., Lefevre, A., Mavel, S., Emond, P., et al. (2021) · Kidney360 · doi:10.34067/kid.0001732021 · Cited by 7
“Our data show disruption of intrarenal redox homeostasis and are consistent with the essential role of MOCOS in aldehyde detoxification (19,20) and the relevance of reactive carbonyl species metabolism in ROS-related renal injury (40,41).”
BackgroundInfluentialJanković, M., Spasojević, N., Ferizović, H., Stefanović, B., Virijević, K., Vezmar, M., & Dronjak, S. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03649-5 · Cited by 7
“The PI3K/Akt signaling pathway is a vital upstream element that is involved in the activation of the NLRP3 inflammasome and inflammatory cytokines and therefore, this pathway may have specific therapeutic effects for depression [14, 15].”
Tissue xanthine oxidoreductase activity in a mouse model of aristolochic acid nephropathy
Ishii, T., Kumagae, T., Wakui, H., Urate, S., Tanaka, S., Abe, E., Suzuki, T., Yamaji, T., Kinguchi, S., Kobayashi, R., et al. (2021) · FEBS Open Bio · doi:10.1002/2211-5463.13083 · Cited by 6
ROS signaling in complex systems: The gut
Knaus, U. G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-818606-0.00033-x · Cited by 6
Gupta, N., & Singh, K. (2025) · Journal of Molecular Histology · doi:10.1007/s10735-025-10507-2 · Cited by 6
“Additionally, studies demonstrate that the activa - tion of NLRP3 inflammasome results in the production of IL-1β and IL-18, which further promotes tissue damage and inflammation (Ives et al. 2015; Ty et al. 2019).”
Chen, T., Wu, X., Wang, D., Cui, T., Li, J., Zhang, Z., Qiu, M., Ma, C., Liu, H., Gao, Y., et al. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.71074 · Cited by 5
“In both obese murine models and human liver tissues, enhanced expression of NLRP3 inflammasome components, increased CASPASE-1 activity, and elevated levels of IL-1β have been observed, correlating directly with the severity of metabolic syndrome phenotypes (Ives et al. 2015).”
Singh, L., Kalia, R., Sharma, S., Singh, A., & Dalal, D. (2025) · 3 Biotech · doi:10.1007/s13205-025-04641-7 · Cited by 8
“Physiologically, ROS also activate the PI3K/Akt pathway, and inactivation of glycogen synthase kinase 3 beta (GSK3β) enhances NLRP3 activation and IL-1β generation (Ives et al. 2015 ).”
Metadata
- Authors
- Ives, A., Nomura, J., Martinon, F., Roger, T., LeRoy, D., Miner, J. N., Simon, G., Busso, N., & So, A.
- Affiliations
- Centre Hospitalier Universitaire Vaudois (CH)
- University of Lausanne (CH)
- Corresponding author
- So, Alexander
- Venue
- Nature Communications
- Published
- 2015-03-24
- Volume
- 6
- Issue
- 1
- Pages
- 6555-6555
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4382995
- OpenAlex
- W2049267620
- Cited by
- 264
- References
- 58
- Citations by year
- 2026: 17 · 2025: 31 · 2024: 29 · 2023: 31 · 2022: 26 · 2021: 31 · 2020: 28 · 2019: 24 · 2018: 7 · 2017: 20 · 2016: 14 · 2015: 6
- FWCI
- 6.80
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- SERVAL (Université de Lausanne) (publishedVersion, other-oa)
- IRIS (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310040, 130085)
- Teijin Pharma
- Institute of Rheumatology Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Health Sciences › Medicine › Nephrology › Gout, Hyperuricemia, Uric Acid
- Keywords
- xanthine oxidoreductase, xanthine oxidase, NLRP3 inflammasome, IL-1β secretion, macrophages, reactive oxygen species, mitochondrial reactive oxygen species, PI3K/Akt signaling, caspase-1, uric acid, ATP, lipopolysaccharide, crystal-induced inflammation, inflammasome activation
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Autophagy, Calcium, Calcium Phosphates, Carrier Proteins, Lipopolysaccharides, Macrophages, Mice, Inbred C57BL, Monocytes, Peritonitis, Phosphorylation, Uric Acid, Xanthine Dehydrogenase, Xanthine Oxidase, Blotting, Western, Signal Transduction, Reactive Oxygen Species, Reverse Transcriptase Polymerase Chain Reaction, Caspase 1, Proto-Oncogene Proteins c-akt, Mice, Interleukin-1beta, Gene Knockdown Techniques, Real-Time Polymerase Chain Reaction, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.